The thesis

UiPath delivers Robotic Process Automation solutions, benefiting from AI Buildout with 13.4% YoY revenue growth. The company's gross margin is 82.5%, indicating strong profitability. Despite a medium conviction score of 28/100, the maintained guidance and confident tone in last earnings suggest a stable outlook. The analyst consensus rating is HOLD, with a P/E of 19.7x.

Why now

The company's Q3 2027 revenue guidance of $440-$445 million and ARR guidance of $1.992-$1.997 billion make it an opportune time to reevaluate UiPath's prospects. The maintained full-year 2027 revenue guidance at $1.789 billion indicates management's confidence in the company's growth trajectory.

What to watch

UiPath's Q4 2027 revenue and ARR guidance, as well as the company's ability to maintain its gross margin above 80%, will be crucial indicators of its growth prospects. The actual revenue and ARR numbers for Q3 2027 will provide insight into the company's execution capabilities.

Key risks

Software spending being one of the first budgets companies cut during economic tightening poses a risk to UiPath's growth. The high P/E ratio of 19.7x indicates valuation risk if revenue growth slows down.

Theme exposure

Upcoming catalysts